diff --git a/sites/gstuguideline/com/members-web/gstu/gstu-guideline-index-php-category-id-9.html b/sites/gstuguideline/com/members-web/gstu/gstu-guideline-index-php-category-id-9.html
index bb839026c..13a34bc7e 100644
--- a/sites/gstuguideline/com/members-web/gstu/gstu-guideline-index-php-category-id-9.html
+++ b/sites/gstuguideline/com/members-web/gstu/gstu-guideline-index-php-category-id-9.html
@@ -267,7 +267,10 @@
 								<a href="https://gstu.members-web.com/gstu/guideline/index.php?category_id=10#section-9" rel="noopener noreferrer">
 									分子的残存病変（molecular residual disease: MRD）検査の適正臨床利用に関する見解書
 								</a>
-								<a href="https://gstu.members-web.com/gstu/guideline/index.php?category_id=10#section-10" rel="noopener noreferrer">
+								<a href="https://gstu.members-web.com/gstu/guideline/index.php?category_id=10#section-14" rel="noopener noreferrer">
+									多がん種早期検出（multi-cancer early detection: MCED）検査の適正臨床利用に関する見解書
+								</a>
+								<a href="https://gstu.members-web.com/gstu/guideline/index.php?category_id=10#section-15" rel="noopener noreferrer">
 									次世代シークエンサー等を用いた遺伝子パネル検査に基づくがん診療ガイダンス
 								</a>
 							</div>